Producing medicines and fine chemicals traditionally requires high temperatures, heavy metals and hazardous hydrogen. A group of chemists and engineers at Harvard University has shown that key transformations can be driven by electricity - right at the boundary between water and an organic solvent. The work was published in the journal Nature Catalysis.
The reaction in question is the reduction of a nitro group to a primary amine - one of the most common reactions in the chemical industry. It underlies the production of active ingredients for medicines, agrochemicals and dyes. Usually hydrogen obtained by steam methane reforming is used for this: each kilogram of such hydrogen accounts for roughly 10-12 kg of carbon dioxide equivalent. Alternative methods often require single-use reducing agents and generate a lot of waste.
Electricity could be cleaner, but there is a physical obstacle. Water with dissolved salts conducts current well, but does not dissolve organic compounds. Organic solvents, conversely, dissolve the reagents but conduct electricity poorly. The team found a solution in molecules originally created for flow batteries - devices that store energy in liquid electrolytes.
The researchers used water-soluble phenazines - stable organic compounds. In an electrochemical cell (a device for carrying out reactions under the action of current), they are charged with protons and electrons, and then, together with the organic solution of the target substance, enter the reactor. There the mixture separates, and at the interface the phenazine transfers its charge to the substrate molecule. After that it returns to the aqueous phase and is charged again.
This "shuttle" acts selectively: unlike traditional catalysts, it does not destroy double bonds, alkynes (compounds with a triple bond) or halogen-containing rings. Because the phenazine remains in the water and the product in the organic phase, the target substance is easy to separate. The authors compared the process to vinaigrette: the mixture can be shaken for the reaction, but as it passes through internal partitions it separates again into two streams, one of which is returned to the cell.
To understand the mechanism, the team combined kinetic analysis, surface studies and quantum-chemical modeling. It turned out that the reaction rate is determined not by the reducing power of the "shuttle" but by its adsorption density at the interface - how strongly the molecule tends to be at the boundary surface. In continuous flow mode, the researchers achieved a yield of 91%. An economic analysis showed that the viability of the process strongly depends on the cost and durability of the mediator.
The authors emphasize that this is a laboratory demonstration, not a ready industrial solution. The technology is now being commercialized through the startup Adiabatic Materials, whose co-founders are Michael Aziz, Richard Liu and Zachary Schiffer. The goal is to create reliable domestic supply chains for pharmaceutical starting materials.